Get Real Time Here
| Open10.440 | Close10.320 |
| Vol / Avg.254.152K / 166.743K | Mkt Cap161.873M |
| Day Range9.630 - 10.485 | 52 Wk Range3.110 - 33.500 |
Harpoon Therapeutics Stock (NASDAQ:HARP), Quotes and News Summary
Harpoon Therapeutics Stock (NASDAQ: HARP) stock price, news, charts, stock research, profile.
| Open10.440 | Close10.320 |
| Vol / Avg.254.152K / 166.743K | Mkt Cap161.873M |
| Day Range9.630 - 10.485 | 52 Wk Range3.110 - 33.500 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -3.200 | -0.460 | 2.7400 | ||||
| REV | 4.640M | 4.448M | -192.000K |
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -3.400 | 0.800 | 4.2000 | ||||
| REV | 5.150M | 20.221M | 15.071M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-11-20 | TD Cowen | Tara Bancroft | Initiates Coverage On | Outperform | - | - | - |
| 2023-10-24 | Citigroup | Yigal Nochomovitz | Maintains | BuyBuy | Lowers | 33.00 | 13.00 |
| 2023-09-18 | Citigroup | Yigal Nochomovitz | Maintains | BuyBuy | Lowers | 60.00 | 33.00 |
| 2023-09-14 | HC Wainwright & Co. | Swayampakula Ramakanth | Maintains | BuyBuy | Raises | 4.50 | 7.50 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HARP | Harpoon Therapeutics | -9.3% | 161.9M |
| IPHA | Innate Pharma | 8.64% | 212.9M |
| ALT | Altimmune | 2.57% | 171.4M |
| ARQT | Arcutis Biotherapeutics | -6.37% | 180.3M |
| OPT | Opthea | -25.53% | 145M |
How do I buy Harpoon Therapeutics (HARP) stock?
You can purchase shares of Harpoon Therapeutics (NASDAQ: HARP) through any online brokerage.
Who are Harpoon Therapeutics's (HARP) competitors?
Other companies in Harpoon Therapeutics’s space includes: Innate Pharma (NASDAQ:IPHA), Altimmune (NASDAQ:ALT), Arcutis Biotherapeutics (NASDAQ:ARQT), Opthea (NASDAQ:OPT) and Genfit (NASDAQ:GNFT).
What is the target price for Harpoon Therapeutics (HARP) stock?
The latest price target for Harpoon Therapeutics (NASDAQ: HARP) was reported by TD Cowen on Monday, November 20, 2023. The analyst firm set a price target for 0.00 expecting HARP to fall to within 12 months (a possible -100.00% downside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for Harpoon Therapeutics (HARP)?
The stock price for Harpoon Therapeutics (NASDAQ: HARP) is $9.56 last updated November 28, 2023 at 2:20 PM UTC.
Does Harpoon Therapeutics (HARP) pay a dividend?
There is no dividend information for Harpoon Therapeutics.
When is Harpoon Therapeutics (NASDAQ:HARP) reporting earnings?
Harpoon Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Harpoon Therapeutics (HARP) going to split?
There is no upcoming split for Harpoon Therapeutics.
What sector and industry does Harpoon Therapeutics (HARP) operate in?
Harpoon Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.